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THE BENEFITS OF

FOR EXERCISEINDUCED
PULMONARY
HEMORRHAGE:
50 YEARS OF
SCIENCE AND
CLINICAL
EXPERIENCE
BY KIMBERLY BREWER, DVM,
MSC; CLARA FENGER, DVM, PHD,
DACVIM; AND THOMAS TOBIN,
MRCVS, PHD, DABT

EXERCISE-INDUCED
PULMONARY HEMORRHAGE
The first record of exercise-induced pulmonary hemorrhage (EIPH) or bleeding is
by the Elizabethan author and horse breeder Gervase Markham, who notes in one of
his books on horsemanship in the late 1500s, in good Elizabethan English, that:
“Many horfes [efpecially young horfes] are often fubject to this Bleeding at
the Nofe, which I imagine proceedeth either from the much abundance of Blood, or
that the Vein, which endeth in that Place is either broken, fretted or opened.”
Markham was describing the post-exercise presentation of blood at the
nostrils, the obvious presentation of what we now know as EIPH. Horsemen had
long suspected that horses also bled into their lungs during vigorous exercise,
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but visualization of such internal bleeding required development of the fiberoptic endoscope.
As long ago as the early 1700s, when the foundation sires of the Thoroughbred breed were racing and breeding, EIPH was recognized as epistaxis, or
bleeding from the nose. One of the most prolific sires was Bartlett’s Childers,
also known as Bleeding Childers for his propensity to bleed from the nose.
Bartlett’s Childers was unraced but distinguished himself as the great-greatgrandsire of Eclipse, who is represented in the pedigree of every modern-day
Thoroughbred. The flexible fiberoptic endoscope that came into use in the 1970s
led to the discovery that a high percentage of exercised horses showed varying
degrees of bleeding in their windpipes following strenuous exercise. What had
been observed for centuries—post-race bleeding from the nose—had only been
the tip of the iceberg, accounting for about 4 percent of EIPH cases.
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EIPH is a hemorrhage that occurs in the lungs of animals, including horses,
camels and greyhounds, and even in elite human athletes during strenuous exercise.
In horses, this hemorrhage occurs in polo horses, show and event horses, barrel
racing horses and any other equine athletes participating in any endeavor in which
strenuous exercise is required. Airway examination suggests that almost all racehorses experience some degree of EIPH—50 percent to 95 percent with well over 90
percent of horses showing blood in their tracheas at some time in their careers.
This hemorrhage occurs when the thin membrane between the capillaries
and alveolar air sacs fails due to the pressure within the pulmonary capillaries
of the lung. The blood in the lungs, along with the damage from the ruptured
capillaries, results in inflammation that heals with scarring, and the damaged lung tissue loses its natural ability to expand and contract. The disease
is progressive and cumulative, with the scientifically demonstrated result of
permanent lesions in the lungs.
In most initial cases, the hemorrhage is slight, but as more capillaries fail,
the bleeding can be marked, even resulting at times in acute fatal hemorrhage.
In extreme cases, the bleeding from the lungs can result in blood coming out
of the nostrils as the horse runs. In this situation, the horse is in danger of faltering, thus endangering itself, its rider and the other horses and riders. In the
past, before Lasix was approved for use, horses died acutely on the racetrack
from EIPH. With the advent of using Lasix in horse racing, the incidence of these
catastrophic events has been significantly reduced.

CAUSES OF EIPH
EIPH is caused by stress failure or the rupture of pulmonary capillaries
because of the high pulmonary capillary pressures that occur during strenuous
exercise. It remains one of the most researched conditions of the racehorse, and
the preponderance of the scientific literature has revealed the following:
1. When EIPH is not controlled, a cycle of hemorrhage, inflammatory
reaction and more hemorrhage occurs.
2. EIPH may occur at any age.
3. EIPH has not been established to be an inherited trait.
4. EIPH occurs with high frequency in both sexes.

DIAGNOSIS OF EIPH
EIPH presents in a number of ways, including the following:
Bleeding from the nose (epistaxis): Readily obvious and recognized
historically, even before the inception of the Thoroughbred breed in the 1700s.
May be observable in up to 4 percent of horses post-exercise.
Blood in the trachea: Readily observed by post-race endoscopic examination of the trachea. The flexible fiberoptic endoscope permits visual examination
of the respiratory tract down into the major bronchi to each lung. All racetrack
veterinarians carry a flexible endoscope, and this is the most common means of
evaluation of both the upper airway and lungs of the horse.
Microscopic evidence of hemorrhage: Broncho alveolar lavage fluid (BAL)
collection involves injecting sterile fluid into the bronchi followed by collecting
this fluid to be examined microscopically. This procedure detects the subtlest
form of EIPH: minimal bleeding not observable by endoscopic examination.
Essentially 100 percent of horses in training test BAL positive for EIPH.
Post-mortem examination: In a small fraction of cases, horses bleed acutely into their lungs and die on the racetrack, sometimes with no obvious evidence
of blood at the nostrils. EIPH has been reported as being the cause of between
50 percent and 80 percent of acute non-musculoskeletal injury-driven deaths in
racehorses. Because blood may not be apparent at the nostrils, a full necropsy
is required to definitively identify cases of acute death caused by EIPH.
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CONTROL AND TREATMENT
OF EIPH
Control is by far the best approach to EIPH, and the best method of EIPH
control is pre-exercise administration of the diuretic Lasix. Administration of
Lasix pre-exercise has been definitively shown to decrease the incidence and
severity of EIPH. In 2009 gold standard-quality research by Australian professor
Ken W. Hinchcliff and colleagues showed that Lasix decreases the incidence and
severity of EIPH, findings the American College of Veterinary Internal Medicine
concurred with.
No control measure for EIPH has been studied to the same extent as Lasix.
Many others have been tried, including medications that enhance clotting,
improve capillary stability or decrease blood clot reduction. Of those medications, most have failed to demonstrate effectiveness. Once it was discovered
that Lasix helps to prevent EIPH, some horsemen began to withhold water for up
to 24 hours before racing or strenuous training. There is no scientific evidence
that this practice is effective, and it could be considered inhumane. Concern
also remains that this practice may be used in countries where race-day Lasix
is not permitted and may be a significant part of plan B approaches to EIPH in
jurisdictions that choose to ban Lasix.
Once EIPH has occurred, treatment is directed at controlling the inflammation and clearing the blood and inflammatory debris from the lungs. Some
veterinarians prescribe antibiotics to prevent bacterial colonization of the blood,
bronchodilators to aid in removal of the blood and even hyperbaric oxygen
therapy to accelerate healing. If severe enough, lung rest, such as restricting
fast exercise, is required during the healing process.

WHAT IS LASIX?
Lasix is a short-acting diuretic, or “water pill,” patented in 1959 and
approved for use in 1964. It is used most commonly for swelling or edema
resulting from heart failure or liver or kidney disease, as well as high blood
pressure. It is on the World Health Organization’s list of essential medicines as
one of the most effective and safe medications needed in a health system. Tens
of millions of people take this medication daily. Lasix has also been used to
prevent EIPH in horses for more than 40 years, and approximately 90 percent of
horses running in North America are administered this preventative medication
before racing. Lasix is recommended by every major U.S. veterinary organization
to protect the health and welfare of the racehorse.
The effect of Lasix when administered intravenously peaks at 30 minutes,
with return of the urine to pre-Lasix concentrations within about 2 ½ hours.
Lasix reduces right atrial blood pressure for up to three hours postadministration and lowers pulmonary capillary blood pressure for up to four
hours post-administration. For its protective effect, Lasix must be administered
on race day and no more than four hours before the race. Dehydration due to
Lasix is minimal, and return to normal values occurs even before the strenuous
exercise or race occurs.

THE HISTORY OF LASIX
USE IN AMERICAN HORSE RACING
It has long been rumored that the then-recently FDA-approved diuretic
Lasix was used to control EIPH in Northern Dancer’s victory in the 1964 Kentucky
Derby. A decade later, in 1974, the use of Lasix was legalized on race day in
Maryland. Two years later, a committee led by Dr. Al Gabel of the American
Association of Equine Practitioners reported to the National Association of
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authority rather than by private practitioners. In addition to the four-hour rule,
drug testing in horses has moved away from urine-based testing to blood
testing, which also helps since Lasix has no significant effect on the detection
of substances in blood.

State Racing Commissioners that Lasix “helped prevent epistaxis” and that
“in many cases it restores normal performance of horses which bleed.” With
strong support from the veterinary and racing community, all U.S. racing
jurisdictions, except for New York, rapidly adopted a three- to four-hour prerace Lasix rule. As the last holdout state, New York finally adopted the rule in
1995 and immediately saw a nearly 80 percent decrease in the incidence of
post-race epistaxis (See chart below).

IS LASIX PERFORMANCEENHANCING?

LASIX’S EFFECT ON THE ABILITY
TO DETECT DRUGS

Some have claimed that Lasix is performance-enhancing, so let’s review a
few things:
• EIPH has clearly been shown to negatively affect the performance of
a horse, a fact that is not hard to understand given that blood in the
lungs can dramatically interfere with a horse’s ability to use oxygen.
• Numerous scientific studies have shown that Lasix decreases the
severity of EIPH.
• The majority of horses performing at maximal exertion will experience
EIPH at some time or another.
• It is therefore not surprising that when studies have looked specifically at the performance of horses racing with Lasix, the medication
was associated with better performance.

MINGIS – STOCK.ADOBE.COM

In human drug testing, diuretics present a significant concern as masking
or diluting agents. This is because most drug testing in humans is performed
on urine samples, and anything that dilutes the urine may well dilute prohibited substances to the point of making them undetectable. Horse racing shared
this concern when Lasix use was being adopted many decades ago, but the
racing industry addressed the issue by establishing the four-hour rule, whereby
Lasix was administered intravenously at four hours before a race. As stated
earlier, the diuretic effect abates about 2 ½ hours after administration, leaving
a full 1 ½ hours before the horse goes to post. Most states now regulate
that Lasix must be administered by veterinarians employed by a regulatory

Figure 1 Effect of Furosemide on Epistaxis Cases/Year in New York Racing

EPISTAXIS CASES IN NEW YORK PRE- AND POST-LASIX APPROVAL
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Does Lasix improve performance if there is no EIPH? Only a few studies
have been designed to answer this question.
A study using tracheobronchoscopy found that male and female horses that
did not bleed with or without Lasix had no performance enhancement from the
administration of the medication, but geldings (castrated males) did. However,
in that study, horses were raced first without Lasix, raced next with Lasix and
then raced again without Lasix. Out of the 665 horses initially examined, only
79 exhibited no EIPH over the three races. Of those, only a group of 18 geldings
demonstrated improved performance when Lasix was added. Curiously, in the
third race, when the same geldings raced without Lasix, their form did not
return to the original no-Lasix performance, indicating that the improvement in
the second race was unlikely to be related to the administration of Lasix.
Another study was performed on a treadmill using oxygen consumption as
a measure of performance. Because oxygen is used to generate energy, this is
commonly equated to performance. This study found that Lasix made the horses
lose weight and that the oxygen consumption per pound improved—but not
the overall oxygen consumption per horse! Since races are run by whole horses,
and not by the pound, this is further evidence that Lasix does not enhance
performance, aside from its effect on reducing EIPH.

WHY DOES THE “NEW WORLD”
ALLOW THE USE OF LASIX ON
RACE DAY?
In countries where EIPH is often identified only through nasal bleeding, only 4
percent of actual EIPH cases are identified. Fortunately for the horse, the trainers
in those countries do realize the benefits of using Lasix in training their horses.
However, they are not allowed to use Lasix on race day—when the horse is going
to have to give maximum effort. International markets for prospective racehorses
often claim that their horses are superior because they race free of Lasix and EIPH,
but despite this claim, American Thoroughbred bloodlines continue to dominate
throughout the world. Further, many of the most prominent buyers of American
horses are people that race outside this country. Not recognizing the proven
high incidence of EIPH is one thing, but to also ignore the mounting evidence
that, uncontrolled, EIPH can lead to chronic, progressive lung pathology appears
hypocritical and is largely unacceptable to the trainers, veterinarians and most of
the owners in North America. This statement is backed by a National Horsemen’s
Benevolent & Protective Association poll in which more than 90 percent of the
owners and trainers were in favor of the use of Lasix on the day of the race. The
North American racing industry is the largest racing industry in the world by far.
To capitulate to the balance of the “Old World” is a little like the tail wagging
the dog, especially in light of the substantial scientific evidence supporting the
benefits of Lasix to the equine athlete.

WHY SHOULD HORSE RACING
AND OTHER USES OF THE HORSE IN
WHICH STRENUOUS EXERCISE IS
REQUIRED REMAIN A VIABLE
COMPONENT OF OUR SOCIETY?
According to the 2017 Economic Impact Study of the American Horse Council, in the United States, more than $50 billion is directly attributable to horses,
and including indirect effects, the contribution is more than $122 billion. Direct
employment in the horse industry is almost 500,000 full-time jobs, and the indirect impact contributes more than 1.7 million jobs. Green space preservation
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provided by the horse industry totals 81 million acres, including 32 million acres
of deeded land and 49 million acres of land leased for horse-related activities.
Therefore, despite the average American having minimal direct interaction
with horses, these animals continue to significantly impact the lives of us all.
Those directly involved in the horse racing industry are in awe of these magnificent athletes. Through gambling, entertainment and the sheer enjoyment of
watching the most elite of athletes perform, all while preserving green space,
often in metropolitan areas where such space is limited, horse racing provides
all Americans with valuable benefits.

THE PROBLEM, IN OUR OPINION
Modern medicine has greatly benefited mankind. In human medicine, infant
mortality has fallen by 60 percent since the time Lasix was introduced in horse
racing, and human life expectancy has increased from 55 to 75 years during
that time. These improvements in human health are due, in part, to modern
medicine and health care.
Advances in veterinary medicine, such as the introduction of the flexible
fiberoptic endoscope, have paralleled the advances in human health. Advocates
for severe restrictions on medications for racehorses would have medical decisions for our cherished athletes made not by the animal’s own veterinarian in
consultation with the owner and trainer but by administrators in a corner office,
guided by perceptions and traditions of the Old World. This would be absurd and
cruel, just as it would be to deprive any animal or human of the benefits that
modern medicine makes possible.
Modern therapeutic medications do not enhance performance, nor do they
contribute in any way to adverse events occurring at the racetrack. Therapeutic
medications improve horses’ quality of life, and arguments to restrict such
medications direct precious resources away from investigation of the true causes
of some of our industry’s problems. The medication of racehorses is more strictly
regulated than medications for human athletes or for those entrusted with our
safety such as airline pilots, ship captains and bus drivers. And yet some unreasonable individuals and organizations attempt to restrict medication even further.
They seem to forget or do not recognize that a racehorse is an athlete.
An example of this “blame the medication” mentality is the recent response
to the injuries at Santa Anita Park in California. It is disingenuous and misleading to suggest that the use of race-day Lasix was in any way associated
with these injuries; in fact, if anything, Lasix decreases the likelihood of injury
to both the racehorse and the jockey. Santa Anita did not have the increase in
injuries in the past, and the trainers, veterinarians and apparently some other
racetrack personnel were the same. If the weather was a factor, it was more
likely related to how the track was maintained during the rainy weather and
not the weather itself since Los Alamitos (less than 30 miles away) and Golden
Gate, located in the same state and receiving about the same rainfall, did not
experience similar increases in injuries.
If a stretch of highway is associated with excessive fatalities, we send out a
team of engineers to determine how that stretch differs from other, safer roads.
Then the road is modified in response to the investigation. This cannot guarantee
that no fatalities will ever occur there, but it does return the safety to the same
level as any other stretch of highway. The same type of investigation needs to
be conducted every time there is any spike in severe injuries on a racetrack. The
racing surface, the track base, the cushion and how it is managed in the face of
weather all require careful evaluation. Such investigation should include all facets
of the industry: horsemen, jockeys, racehorse veterinarians and track managers.
One thing is certain—Lasix, in use for 40 years at every racetrack in California,
had no role in that two-month spike in injuries at Santa Anita.
For more information on the facts concerning Lasix and EIPH, visit
lasixeiphfacts.com. HJ
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